We present the case of a patient with an elevated prostate-specific antigen level who underwent a prostate MRI that revealed a mass between the prostate and rectum, prompting further evaluation.

Journal of Nuclear Medicine Technology March 2026, jnmt.125.271571; DOI: https://doi.org/10.2967/jnmt.125.271571 ...

Journal of Nuclear Medicine Technology March 2026, jnmt.125.271050; DOI: https://doi.org/10.2967/jnmt.125.271050 ...

Journal of Nuclear Medicine Technology March 2026, jnmt.125.271806; DOI: https://doi.org/10.2967/jnmt.125.271806 ...

Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...

Neurodegenerative diseases are characterized by progressive neuronal dysfunction, synaptic loss, and decline in cognitive, behavioral, or motor function. Understanding these disorders requires a ...

Neurodegenerative disease profoundly affects structures and pathways responsible for memory, cognition, and higher-order processing. A foundational understanding of neuroanatomy and physiology is ...

The approval of disease-modifying antiamyloid therapies has expanded the clinical role of amyloid PET beyond diagnostic confirmation to include baseline characterization and longitudinal monitoring of ...

Alzheimer disease (AD) is the most common cause of dementia and one of the leading causes of death in adults age 65 y or older in the United States. AD presents with symptoms of cognitive impairment ...

In this study, we aimed to quantify the impact of data-driven motion-correction reconstruction for PET imaging on still and motion-corrupted 18F-FDG PET brain scans of children and adolescents.

The growing demand for amyloid and tau PET imaging, driven by new dementia therapies and biomarker-based diagnosis, has increased the need for accessible PET brain imaging in outpatient neurology ...